Global Intravenous (IV) Iron Drugs Market Professional Survey Report 2018

March 2018 | 103 pages | ID: GDAFA98CE58EN
QYResearch

Abstracts

This report studies Intravenous (IV) Iron Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Sanofi US
• Allergan
• AMAG Pharmaceuticals
• Dalichi Sankyo
• Luitpold Pharmaceuticals
• Pharmacosmos
• Takeda Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Ferric Carboxymaltose
• Iron Sucrose
• Iron Dextran
• Others

By Application, the market can be split into

• Nephrology
• Gynecology & Obstetrics
• Gastroenterology
• Oncology
• Cardiology
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Intravenous (IV) Iron Drugs Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF INTRAVENOUS (IV) IRON DRUGS

1.1 Definition and Specifications of Intravenous (IV) Iron Drugs
  1.1.1 Definition of Intravenous (IV) Iron Drugs
  1.1.2 Specifications of Intravenous (IV) Iron Drugs
1.2 Classification of Intravenous (IV) Iron Drugs
  1.2.1 Ferric Carboxymaltose
  1.2.2 Iron Sucrose
  1.2.3 Iron Dextran
  1.2.4 Others
1.3 Applications of Intravenous (IV) Iron Drugs
  1.3.1 Nephrology
  1.3.2 Gynecology & Obstetrics
  1.3.3 Gastroenterology
  1.3.4 Oncology
  1.3.5 Cardiology
  1.3.6 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF INTRAVENOUS (IV) IRON DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Intravenous (IV) Iron Drugs
2.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
2.4 Industry Chain Structure of Intravenous (IV) Iron Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF INTRAVENOUS (IV) IRON DRUGS

3.1 Capacity and Commercial Production Date of Global Intravenous (IV) Iron Drugs Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Intravenous (IV) Iron Drugs Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Intravenous (IV) Iron Drugs Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Intravenous (IV) Iron Drugs Major Manufacturers in 2017

4 GLOBAL INTRAVENOUS (IV) IRON DRUGS OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Intravenous (IV) Iron Drugs Capacity and Growth Rate Analysis
  4.2.2 2017 Intravenous (IV) Iron Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Intravenous (IV) Iron Drugs Sales and Growth Rate Analysis
  4.3.2 2017 Intravenous (IV) Iron Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Intravenous (IV) Iron Drugs Sales Price
  4.4.2 2017 Intravenous (IV) Iron Drugs Sales Price Analysis (Company Segment)

5 INTRAVENOUS (IV) IRON DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Intravenous (IV) Iron Drugs Market Analysis
  5.1.1 North America Intravenous (IV) Iron Drugs Market Overview
  5.1.2 North America 2013-2018E Intravenous (IV) Iron Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Intravenous (IV) Iron Drugs Sales Price Analysis
  5.1.4 North America 2017 Intravenous (IV) Iron Drugs Market Share Analysis
5.2 China Intravenous (IV) Iron Drugs Market Analysis
  5.2.1 China Intravenous (IV) Iron Drugs Market Overview
  5.2.2 China 2013-2018E Intravenous (IV) Iron Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Intravenous (IV) Iron Drugs Sales Price Analysis
  5.2.4 China 2017 Intravenous (IV) Iron Drugs Market Share Analysis
5.3 Europe Intravenous (IV) Iron Drugs Market Analysis
  5.3.1 Europe Intravenous (IV) Iron Drugs Market Overview
  5.3.2 Europe 2013-2018E Intravenous (IV) Iron Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Intravenous (IV) Iron Drugs Sales Price Analysis
  5.3.4 Europe 2017 Intravenous (IV) Iron Drugs Market Share Analysis
5.4 Southeast Asia Intravenous (IV) Iron Drugs Market Analysis
  5.4.1 Southeast Asia Intravenous (IV) Iron Drugs Market Overview
  5.4.2 Southeast Asia 2013-2018E Intravenous (IV) Iron Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Intravenous (IV) Iron Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2017 Intravenous (IV) Iron Drugs Market Share Analysis
5.5 Japan Intravenous (IV) Iron Drugs Market Analysis
  5.5.1 Japan Intravenous (IV) Iron Drugs Market Overview
  5.5.2 Japan 2013-2018E Intravenous (IV) Iron Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Intravenous (IV) Iron Drugs Sales Price Analysis
  5.5.4 Japan 2017 Intravenous (IV) Iron Drugs Market Share Analysis
5.6 India Intravenous (IV) Iron Drugs Market Analysis
  5.6.1 India Intravenous (IV) Iron Drugs Market Overview
  5.6.2 India 2013-2018E Intravenous (IV) Iron Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Intravenous (IV) Iron Drugs Sales Price Analysis
  5.6.4 India 2017 Intravenous (IV) Iron Drugs Market Share Analysis

6 GLOBAL 2013-2018E INTRAVENOUS (IV) IRON DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Intravenous (IV) Iron Drugs Sales by Type
6.2 Different Types of Intravenous (IV) Iron Drugs Product Interview Price Analysis
6.3 Different Types of Intravenous (IV) Iron Drugs Product Driving Factors Analysis
  6.3.1 Ferric Carboxymaltose of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis
  6.3.2 Iron Sucrose of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis
  6.3.3 Iron Dextran of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis
  6.3.4 Others of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis

7 GLOBAL 2013-2018E INTRAVENOUS (IV) IRON DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Intravenous (IV) Iron Drugs Consumption by Application
7.2 Different Application of Intravenous (IV) Iron Drugs Product Interview Price Analysis
7.3 Different Application of Intravenous (IV) Iron Drugs Product Driving Factors Analysis
  7.3.1 Nephrology of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis
  7.3.2 Gynecology & Obstetrics of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis
  7.3.3 Gastroenterology of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis
  7.3.4 Oncology of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis
  7.3.5 Cardiology of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis
  7.3.6 Others of Intravenous (IV) Iron Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF INTRAVENOUS (IV) IRON DRUGS

8.1 Sanofi US
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Sanofi US 2017 Intravenous (IV) Iron Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Sanofi US 2017 Intravenous (IV) Iron Drugs Business Region Distribution Analysis
8.2 Allergan
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Allergan 2017 Intravenous (IV) Iron Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Allergan 2017 Intravenous (IV) Iron Drugs Business Region Distribution Analysis
8.3 AMAG Pharmaceuticals
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 AMAG Pharmaceuticals 2017 Intravenous (IV) Iron Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 AMAG Pharmaceuticals 2017 Intravenous (IV) Iron Drugs Business Region Distribution Analysis
8.4 Dalichi Sankyo
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Dalichi Sankyo 2017 Intravenous (IV) Iron Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Dalichi Sankyo 2017 Intravenous (IV) Iron Drugs Business Region Distribution Analysis
8.5 Luitpold Pharmaceuticals
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Luitpold Pharmaceuticals 2017 Intravenous (IV) Iron Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Luitpold Pharmaceuticals 2017 Intravenous (IV) Iron Drugs Business Region Distribution Analysis
8.6 Pharmacosmos
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Pharmacosmos 2017 Intravenous (IV) Iron Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Pharmacosmos 2017 Intravenous (IV) Iron Drugs Business Region Distribution Analysis
8.7 Takeda Pharmaceutical
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Takeda Pharmaceutical 2017 Intravenous (IV) Iron Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Takeda Pharmaceutical 2017 Intravenous (IV) Iron Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF INTRAVENOUS (IV) IRON DRUGS MARKET

9.1 Global Intravenous (IV) Iron Drugs Market Trend Analysis
  9.1.1 Global 2018-2025 Intravenous (IV) Iron Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Intravenous (IV) Iron Drugs Sales Price Forecast
9.2 Intravenous (IV) Iron Drugs Regional Market Trend
  9.2.1 North America 2018-2025 Intravenous (IV) Iron Drugs Consumption Forecast
  9.2.2 China 2018-2025 Intravenous (IV) Iron Drugs Consumption Forecast
  9.2.3 Europe 2018-2025 Intravenous (IV) Iron Drugs Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Intravenous (IV) Iron Drugs Consumption Forecast
  9.2.5 Japan 2018-2025 Intravenous (IV) Iron Drugs Consumption Forecast
  9.2.6 India 2018-2025 Intravenous (IV) Iron Drugs Consumption Forecast
9.3 Intravenous (IV) Iron Drugs Market Trend (Product Type)
9.4 Intravenous (IV) Iron Drugs Market Trend (Application)

10 INTRAVENOUS (IV) IRON DRUGS MARKETING TYPE ANALYSIS

10.1 Intravenous (IV) Iron Drugs Regional Marketing Type Analysis
10.2 Intravenous (IV) Iron Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Intravenous (IV) Iron Drugs by Region
10.4 Intravenous (IV) Iron Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF INTRAVENOUS (IV) IRON DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL INTRAVENOUS (IV) IRON DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Intravenous (IV) Iron Drugs
Table Product Specifications of Intravenous (IV) Iron Drugs
Table Classification of Intravenous (IV) Iron Drugs
Figure Global Production Market Share of Intravenous (IV) Iron Drugs by Type in 2017
Figure Ferric Carboxymaltose Picture
Table Major Manufacturers of Ferric Carboxymaltose
Figure Iron Sucrose Picture
Table Major Manufacturers of Iron Sucrose
Figure Iron Dextran Picture
Table Major Manufacturers of Iron Dextran
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Intravenous (IV) Iron Drugs
Figure Global Consumption Volume Market Share of Intravenous (IV) Iron Drugs by Application in 2017
Figure Nephrology Examples
Table Major Consumers in Nephrology
Figure Gynecology & Obstetrics Examples
Table Major Consumers in Gynecology & Obstetrics
Figure Gastroenterology Examples
Table Major Consumers in Gastroenterology
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Cardiology Examples
Table Major Consumers in Cardiology
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Intravenous (IV) Iron Drugs by Regions
Figure North America Intravenous (IV) Iron Drugs Market Size (Million USD) (2013-2025)
Figure China Intravenous (IV) Iron Drugs Market Size (Million USD) (2013-2025)
Figure Europe Intravenous (IV) Iron Drugs Market Size (Million USD) (2013-2025)
Figure Southeast Asia Intravenous (IV) Iron Drugs Market Size (Million USD) (2013-2025)
Figure Japan Intravenous (IV) Iron Drugs Market Size (Million USD) (2013-2025)
Figure India Intravenous (IV) Iron Drugs Market Size (Million USD) (2013-2025)
Table Intravenous (IV) Iron Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Intravenous (IV) Iron Drugs in 2017
Figure Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
Figure Industry Chain Structure of Intravenous (IV) Iron Drugs
Table Capacity and Commercial Production Date of Global Intravenous (IV) Iron Drugs Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Intravenous (IV) Iron Drugs Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Intravenous (IV) Iron Drugs Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Intravenous (IV) Iron Drugs Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Intravenous (IV) Iron Drugs 2013-2018E
Figure Global 2013-2018E Intravenous (IV) Iron Drugs Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Intravenous (IV) Iron Drugs Market Size (Value) and Growth Rate
Table 2013-2018E Global Intravenous (IV) Iron Drugs Capacity and Growth Rate
Table 2017 Global Intravenous (IV) Iron Drugs Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Intravenous (IV) Iron Drugs Sales (K Units) and Growth Rate
Table 2017 Global Intravenous (IV) Iron Drugs Sales (K Units) List (Company Segment)
Table 2013-2018E Global Intravenous (IV) Iron Drugs Sales Price (USD/Unit)
Table 2017 Global Intravenous (IV) Iron Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Intravenous (IV) Iron Drugs 2013-2018E
Figure North America 2013-2018E Intravenous (IV) Iron Drugs Sales Price (USD/Unit)
Figure North America 2017 Intravenous (IV) Iron Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Intravenous (IV) Iron Drugs 2013-2018E
Figure China 2013-2018E Intravenous (IV) Iron Drugs Sales Price (USD/Unit)
Figure China 2017 Intravenous (IV) Iron Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Intravenous (IV) Iron Drugs 2013-2018E
Figure Europe 2013-2018E Intravenous (IV) Iron Drugs Sales Price (USD/Unit)
Figure Europe 2017 Intravenous (IV) Iron Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Intravenous (IV) Iron Drugs 2013-2018E
Figure Southeast Asia 2013-2018E Intravenous (IV) Iron Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2017 Intravenous (IV) Iron Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Intravenous (IV) Iron Drugs 2013-2018E
Figure Japan 2013-2018E Intravenous (IV) Iron Drugs Sales Price (USD/Unit)
Figure Japan 2017 Intravenous (IV) Iron Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Intravenous (IV) Iron Drugs 2013-2018E
Figure India 2013-2018E Intravenous (IV) Iron Drugs Sales Price (USD/Unit)
Figure India 2017 Intravenous (IV) Iron Drugs Sales Market Share
Table Global 2013-2018E Intravenous (IV) Iron Drugs Sales (K Units) by Type
Table Different Types Intravenous (IV) Iron Drugs Product Interview Price
Table Global 2013-2018E Intravenous (IV) Iron Drugs Sales (K Units) by Application
Table Different Application Intravenous (IV) Iron Drugs Product Interview Price
Table Sanofi US Information List
Table Product A Overview
Table Product B Overview
Table 2017 Sanofi US Intravenous (IV) Iron Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Sanofi US Intravenous (IV) Iron Drugs Business Region Distribution
Table Allergan Information List
Table Product A Overview
Table Product B Overview
Table 2017 Allergan Intravenous (IV) Iron Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Allergan Intravenous (IV) Iron Drugs Business Region Distribution
Table AMAG Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2015 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Business Region Distribution
Table Dalichi Sankyo Information List
Table Product A Overview
Table Product B Overview
Table 2017 Dalichi Sankyo Intravenous (IV) Iron Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Dalichi Sankyo Intravenous (IV) Iron Drugs Business Region Distribution
Table Luitpold Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Business Region Distribution
Table Pharmacosmos Information List
Table Product A Overview
Table Product B Overview
Table 2017 Pharmacosmos Intravenous (IV) Iron Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Pharmacosmos Intravenous (IV) Iron Drugs Business Region Distribution
Table Takeda Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2017 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Business Region Distribution
Figure Global 2018-2025 Intravenous (IV) Iron Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Intravenous (IV) Iron Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Intravenous (IV) Iron Drugs Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Intravenous (IV) Iron Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Intravenous (IV) Iron Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Intravenous (IV) Iron Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Intravenous (IV) Iron Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Intravenous (IV) Iron Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Intravenous (IV) Iron Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Intravenous (IV) Iron Drugs by Type 2018-2025
Table Global Consumption Volume (K Units) of Intravenous (IV) Iron Drugs by Application 2018-2025
Table Traders or Distributors with Contact Information of Intravenous (IV) Iron Drugs by Region